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Economic sanctions 
and Iran’s capacity to 
respond to COVID-19
Iran was one of the first countries 
outside China to have a rapid increase 
in the number of cases of coronavirus 
disease 2019 (COVID-19). The country’s 
capacity to respond to the virus is 
substantially impeded by unilateral 
economic sanctions re-imposed after 
the US Administration withdrew 
from the nuclear deal in May, 2018, 
and further US sanctions imposed 
as recently as March 18, 2020.1 As of 
March 31, 2020, the recorded number 
of people infected from COVID-19 in 
Iran was 41 495, with 2757 deaths,2 but 
these numbers are likely a  substantial 
underestimation.
Even before COVID-19, Iran’s health 
system was feeling the effect of the 
sanctions.3 Their impact is now severe 
because they restrict the government’s 
ability to raise funds or to import 
essential goods. Of the ten countries 
with the highest number of recorded 
cases of COVID-19 to date, Iran is the 
poorest.2 In 2019, Iran had the lowest 
rate of economic growth (–9·5%) 
and highest rate of inflation (35·7%) 
recorded in the country for the past 
20 years. This financial situation makes 
the funding of adequate prevention, 
diagnosis, and treatment of COVID-19 
impossible, and the country cannot take 
the same measures adopted in other 
countries to strengthen responses, 
such as paying the full cost of obtaining 
treatment.3 Essential medicines and 
medical equipment are technically 
exempt from sanctions, but their 
availability is restricted by the effect of 
sanctions on the commercial sector, 
reducing manufacturing and trade 
capacity, and on foreign exchange. 
Consequently, although approximately 
184 000 hospital and primary 
health-care staff are working to fight 
COVID-19, their efforts are thwarted 
by shortages of test kits, protective 
equipment, and ventilators. WHO has 
provided crucial supplies, sufficient 
equipment for 31 000 workers, but 
supplies are still substantially short of 
what is needed.
The COVID-19 pandemic has 
occurred at a time of economic crisis 
in Iran, in which steep increases 
in medicine price have affected 
approximately 6 million patients with 
complex and chronic illnesses;4 the 
situation is almost certainly worse 
now. This group of individuals is at 
particularly high risk of infection and 
disease progression.
As stated by the Director-General of 
WHO, “We’re all in this together, and 
we can only save lives together.” He 
was clear that the pandemic caused 
by COVID-19, the spread of which is 
unaffected by national borders, can 
only be controlled by extraordinary 
co-operation between countries, 
putting political differences aside. Like 
elsewhere, delays in implementing 
strict physical distancing measures in 
Iran have likely made management of 
the increasing number of COVID-19 
cases more difficult, but the impact 
of sanctions on the country’s capacity 
to take these measures should not 
be ignored. Some countries (such as 
the UK) and some political leaders 
(including some in the USA), have 
recognised the urgent need to ease US 
sanctions on Iran. But the call to do so 
has achieved little global traction and 
time is running out.
The Organisation for Economic 
Co-operation and Development 
forecasts that global economic 
growth could decrease by 0·5–1·4% 
due to COVID-19.5 The harsh obstacles 
presented by US sanctions mean that 
Iran could bear a disproportionate 
share of this fiscal and health shock, 
leading to its probable economic 
collapse and inability to contain the 
virus that has implications for the 
entire world.
IH is a deputy minister in Iran’s Ministry of Health 
and Medical Education. All other authors declare no 
competing interests.
Copyright © 2020 The Author(s). Published by 
Elsevier Ltd. This is an Open Access article under the 
CC BY 4.0 license. 
Published Online 
April 6, 2020 
https://doi.org/10.1016/ 
S2468-2667(20)30083-9
For World Bank data  on GDP 
per capita per country see 
http://data.worldbank.org/
indicator/NY.GDP.PCAP.CD
For WHO Director General’s 
opening remarks at the media 
briefing on COVID-19, 
March 5, 2020 see https://www.
who.int/dg/speeches/detail/
who-director-general-s-
opening-remarks-at-the-media-
briefing-on-covid-19---5-
march-2020
